Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prospects for chimeric antigen receptor (CAR) γδ T cells: A potential game changer for adoptive T cell cancer immunotherapy.

Cancer letters - 1 Oct 2016

Mirzaei Hamid Reza, Mirzaei Hamed, Lee Sang Yun, Hadjati Jamshid, Till Brian G

Abstract excerpt

Excitement is growing for therapies that harness the power of patients' immune systems to combat their diseases. One approach to immunotherapy involves engineering patients' own T cells to express a chimeric antigen receptor (CAR) to treat advanced cancers, particularly those refractory to conventional therapeutic agents. Although these engineered immune cells have made remarkable strides in the treatment of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Therapy
Share to Immunotherapy, Adoptive

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphocytes, Tumor-Infiltrating

Share to Neoplasms

Share to Receptors, Antigen, T-Cell, gamma-delta

Share to Recombinant Fusion Proteins

Share to T-Lymphocytes

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 27392648
DOI: 10.1016/j.canlet.2016.07.001
PMCID: PMC5003697

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prospects for chimeric antigen receptor (CAR) γδ T cells: A potential game changer for adoptive T cell cancer immunotherapy.PMID 27392648Read ↗

The potential of γδ CAR and TRuC T cells: An unearthed treasureSemantic proximity Read ↗

Cancer Immunotherapy Using γδT Cells: Dealing with DiversitySemantic proximity Read ↗

Role of γδ T Cells in Cancer Progression and Therapy.Semantic proximity Read ↗

γδ T cells in cancer immunotherapy.Semantic proximity Read ↗

Targeting γδ T Lymphocytes for Cancer Immunotherapy: From Novel Mechanistic Insight to Clinical ApplicationSemantic proximity Read ↗

Chimeric Antigen Receptor (CAR) T Cells: A Detailed Review of Origins, Engineering, and Therapeutic ImpactSemantic proximity Read ↗

Derivation of mimetic γδ T cells endowed with cancer recognition receptors from reprogrammed γδ T cellSemantic proximity Read ↗

Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation.Semantic proximity Read ↗

Deciphering human γδ T cell response in cancer: Lessons from tumor‐infiltrating γδ T cellsSemantic proximity Read ↗

Immune Cell Hacking: Challenges and Clinical Approaches to Create Smarter Generations of Chimeric Antigen Receptor T CellsSemantic proximity Read ↗

Human γδ T cells in the tumor microenvironment: Key insights for advancing cancer immunotherapySemantic proximity Read ↗

Emerging Strategies in TCR-Engineered T CellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.